Rogers, J. G., Milano, C. A., Pamboukian, S. V., Bhat, G., Birks, E. J., Najjar, S. S., … Pagani, F. D. (2016). Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial. In The Journal of Heart and Lung Transplantation (Vol. 35, pp. S24–S25). Elsevier BV. https://doi.org/10.1016/j.healun.2016.01.067

Rogers, J. G., C. A. Milano, S. V. Pamboukian, G. Bhat, E. J. Birks, S. S. Najjar, B. B. Reid, D. Meyer, K. Leadley, and F. D. Pagani. “Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial.” In The Journal of Heart and Lung Transplantation, 35:S24–25. Elsevier BV, 2016. https://doi.org/10.1016/j.healun.2016.01.067.

Rogers JG, Milano CA, Pamboukian SV, Bhat G, Birks EJ, Najjar SS, et al. Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial. In: The Journal of Heart and Lung Transplantation. Elsevier BV; 2016. p. S24–5.

Rogers, J. G., et al. “Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial.” The Journal of Heart and Lung Transplantation, vol. 35, no. 4, Elsevier BV, 2016, pp. S24–25. Crossref, doi:10.1016/j.healun.2016.01.067.

Rogers JG, Milano CA, Pamboukian SV, Bhat G, Birks EJ, Najjar SS, Reid BB, Meyer D, Leadley K, Pagani FD. Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial. The Journal of Heart and Lung Transplantation. Elsevier BV; 2016. p. S24–S25.